search
biotechnology
Trends
- 1European Capital Backs Colombian Biotech Firm for 250 Million Vaccines▼Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines
European investors are injecting capital into a Colombian biotechnology company with plans to produce 250 million vaccines. The deal positions Colombia as a growing player in global vaccine manufacturing and reflects Europe's interest in diversifying pharmaceutical production capacity beyond its borders, though details on the funding amount and timeline remain limited.
- 2WSJ warns U.S. tariffs are hurting American biotech●The U.S. Tariff Attack on U.S. Biotech https://www.wsj.com/opinion/the-u-s-tariff-attack-on-u-s-biotech-c3406b92?mod=rss
The Wall Street Journal's opinion section argues that U.S. tariff policy is damaging the domestic biotechnology industry, which the piece frames as an ironic case of Washington's trade measures attacking American companies. The article is being shared in economic and policy discussions, drawing attention to the tension between protectionist trade policy and the administration's stated goal of strengthening U.S. industrial and pharmaceutical sectors.
- 3What's The Latest On CRISPR Gene Editing Technology?▼What’s The Latest On CRISPR Gene Editing Technology?
Forbes is asking what the latest developments are in CRISPR gene editing technology. The field continues to move quickly, with gene-editing therapies and research advancing across medicine and biotechnology. Readers are following the topic as new treatments and regulatory decisions keep gene editing in the public eye.
- 4Healey awards $40M in tax incentives to life science company▼Healey awards $40M in tax incentives to life science company, expected to create 1,600 jobs
Massachusetts Governor Maura Healey has approved $40 million in tax incentives for a life science company, a package state officials say will support the creation of 1,600 jobs. The award is part of the state's ongoing effort to keep and grow its biotechnology and life sciences sector, one of Massachusetts' key industries. Details on the company's identity and expansion site were included in the announcement.
- 5India central to next biotech and AI industrial revolution, says Jitendra Singh●India to be an essential player in the next industrial revolution which will be biotechnology and AI driven: Dr Jitendra Singh
Union minister Dr Jitendra Singh said India will be an essential player in the next industrial revolution, which he described as being driven by biotechnology and artificial intelligence. The statement, issued through the government's press bureau, frames India as a key contributor to emerging technologies, positioning the country's biotech and AI sectors as central to its future economic growth.
- 6Genesis Mission Report Looks at AI in Fusion and Biology▼Genesis Mission Report Examines AI’s Role in Fusion and Biological Design
A new report from the Genesis Mission examines how artificial intelligence is being applied to fusion energy research and biological design. The analysis covers AI's potential to accelerate scientific discovery in these fields, including modeling complex plasma behavior and engineering biological systems. The report is drawing attention from readers following the broader push to apply advanced computing and AI to national science and energy priorities.
- 7Machine Learning Boosts Production of Licorice-Derived Drug Molecule▼Machine Learning and Molecular Scaffolds Supercharge Production of a Licorice-Derived Drug Molecule
Researchers report that combining machine learning with molecular scaffold engineering has significantly increased production of a drug molecule originally derived from licorice. The approach uses computational models to optimize biosynthesis, potentially making plant-derived pharmaceuticals cheaper and more sustainable to manufacture. The work highlights how AI tools are being applied to speed up drug compound production in biotechnology.
- 8Gene editing seen as a tool against global food insecurity●The shining promise of gene editing technology in a food-insecure world
Commentary is highlighting gene editing technology as a promising answer to food insecurity worldwide. The piece argues that tools allowing precise changes to crops and livestock could help farmers produce more food under difficult conditions, including climate pressure and shrinking resources. It adds to an ongoing debate over how gene-edited foods should be regulated and accepted by the public.
- 9Jitendra Singh opens Rs 60 crore recombinant cells facility at BRIC●Jitendra Singh inaugurates Rs 60 crore recombinant cells facility at BRIC
Union Minister Jitendra Singh inaugurated a Rs 60 crore recombinant cells facility at the Biotechnology Research and Innovation Council (BRIC). The new facility is expected to boost India's biotechnology research capacity, supporting work on recombinant cell technology used in medicines and vaccines. The inauguration was reported by national media, highlighting the government's continued investment in science and biotech infrastructure.
- 10Budd and Blunt Rochester Introduce Biometrology Laboratory Bill▼Budd, Blunt Rochester Introduce Bill to Establish Biometrology Laboratory Program, Accelerate Development in Biotech
US Senators Ted Budd and Lisa Blunt Rochester have introduced legislation to establish a Biometrology Laboratory Program aimed at accelerating development in the biotech industry. The bill would create a federal program to advance measurement science in biotechnology. The bipartisan pairing has drawn attention as Congress weighs support for the US biotech sector.
- 11Startup seeks to prove embryo gene-editing is safe for healthy babies●This startup wants to prove gene-editing embryos is safe for making healthy babies
A startup is working to demonstrate that gene-editing human embryos can be done safely, with the aim of producing babies free of inherited disease. The effort touches one of the most contested areas in biotechnology, where editing of embryos has previously triggered international condemnation, and is likely to reignite debate among scientists, ethicists and regulators about where the line should be drawn.
- 12Machine Learning Reveals Hidden Gene Switches in Fungi▼Machine Learning Hunts Down Hidden Gene Switches Across the Fungal Tree of Life
Researchers are using machine learning to identify previously unknown gene regulatory switches across the fungal tree of life, according to a new report. The approach could help scientists understand how fungi control gene expression in different species, with potential applications in biotechnology, medicine, and agriculture. The work highlights how AI tools are increasingly being applied to comparative genomics and biology.
- 13
BioTech New Zealand has announced the formation of a new engineering biology group, aimed at advancing the emerging field of engineered biology in the country. The initiative is expected to bring together industry, researchers and policymakers to support development and commercialisation of biotechnology in New Zealand.
- 14Plantik and Hudson River Biotechnology partner on heat-tolerant strawberries●Exclusive: Plantik and Hudson River Biotechnology team up to de-risk heat-tolerant strawberries
Plantik Biosciences and Hudson River Biotechnology have announced a partnership to develop strawberry varieties that can withstand rising temperatures, aiming to de-risk development of heat-tolerant fruit crops. The collaboration pairs Plantik's crop-breeding technology with Hudson River Biotechnology's plant cell engineering platform, as agriculture faces mounting pressure from climate change.
- 15Endpoints News Names 2026 Endpoints 11 Award Winners▼Endpoints News Announces the 2026 Winners of the Endpoints 11 Awards, showcasing biotech’s most exciting startups
Endpoints News has announced the winners of its 2026 Endpoints 11 Awards, an annual list honoring the most promising startups in biotechnology. The awards spotlight early-stage biotech companies considered the most exciting in the industry, drawing attention from investors, researchers and life-science professionals tracking which emerging firms could shape the next wave of drug development.
- 16
Former Genentech artificial intelligence staff have launched Ortet, a new health-focused startup, backed by $500 million in funding. The company will apply AI to drug discovery and healthcare development, drawing on the founders' experience at one of the world's leading biotechnology firms. The large initial funding round makes Ortet one of the most heavily financed health AI launches to date.
- 17Pittsburgh biotech partners with Boston company to form startup▼Pittsburgh biotech partners with Boston-area company, forming new startup
A Pittsburgh biotechnology company has partnered with a Boston-area firm to launch a new startup, according to the Pittsburgh Post-Gazette. The move links the two regional biotech hubs and could bring combined research and commercial capabilities under one new venture. Details about the companies' names, funding and focus have not yet been widely reported.
- 18Scientists refine targeting of cell-surface proteins▼Targeting cell-surface proteins with greater precision
News-Medical reports on advances allowing researchers to target cell-surface proteins with greater precision, a development relevant to drug delivery and therapeutic design. Cell-surface proteins are key entry points for medicines, so improved targeting accuracy could mean more effective treatments with fewer side effects. The report has drawn attention from readers following progress in biotechnology and molecular medicine.
- 19AllyGPO Wins Stevie Award for Pharma Technology Excellence▼AllyGPO Wins Stevie Award for Technology Excellence in Pharmaceuticals and Biotechnology
AllyGPO has won a Stevie Award for Technology Excellence in the Pharmaceuticals and Biotechnology category. The recognition honours the company's technology work serving the healthcare group purchasing sector. The announcement was made via press release, and details on the specific product or project recognised were not provided.